TCM
ELV icon

Tekla Capital Management’s Elevance Health ELV Stock Holding History

Tekla Capital Management’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		$50.7M Hold
114,070
– – 1.98% 16
2023
Q1 		$52.5M Buy
114,070
+99,426
+679% +$47.3M 2% 16
2022
Q4 		$7.51M Hold
14,644
– – 0.28% 67
2022
Q3 		$6.65M Hold
14,644
– – 0.27% 69
2022
Q2 		$7.07M Hold
14,644
– – 0.28% 71
2022
Q1 		$7.19M Hold
14,644
– – 0.25% 76
2021
Q4 		$6.79M Hold
14,644
– – 0.22% 87
2021
Q3 		$5.46M Sell
14,644
-93,090
-86% -$35.4M 0.18% 103
2021
Q2 		$41.1M Sell
107,734
-57,043
-35% -$21.8M 1.34% 20
2021
Q1 		$59.1M Buy
164,777
+127,644
+344% +$41M 2.03% 13
2020
Q4 		$11.9M Hold
37,133
– – 0.42% 70
2020
Q3 		$9.97M Sell
37,133
-3,109
-8% -$837K 0.37% 62
2020
Q2 		$10.6M Sell
40,242
-25,326
-39% -$6.76M 0.4% 52
2020
Q1 		$14.9M Sell
65,568
-36,464
-36% -$9.94M 0.67% 34
2019
Q4 		$30.8M Sell
102,032
-19,100
-16% -$5.26M 1.17% 20
2019
Q3 		$29.1M Buy
121,132
+17,676
+17% +$4.84M 1.27% 20
2019
Q2 		$29.2M Sell
103,456
-37,902
-27% -$10.4M 1.19% 20
2019
Q1 		$40.6M Buy
141,358
+211
+0.1% +$61K 1.65% 15
2018
Q4 		$37.1M Hold
141,147
– – 1.59% 18
2018
Q3 		$38.7M Buy
141,147
+30,514
+28% +$7.92M 1.4% 18
2018
Q2 		$26.3M Buy
110,633
+19,151
+21% +$4.43M 1% 28
2018
Q1 		$20.1M Buy
91,482
+46,564
+104% +$10.9M 0.78% 31
2017
Q4 		$10.1M Hold
44,918
– – 0.39% 54
2017
Q3 		$8.53M Buy
+44,918
New +$8.55M 0.3% 63

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Tekla Capital Management's ELV Position: Q2 2023 in Review

Tekla Capital Management held its Elevance Health (ELV) position steady in Q2 2023 at 114,070 shares worth $50.7M. The position accounts for 1.98% of the portfolio, ranked #16.

Tekla Capital Management first reported a position in ELV in Q3 2017 and has held it in 24 quarters since. The position peaked at $59.1M in Q1 2021. 1,524 funds tracked by Wall St. Rank hold ELV as of Q2 2023.

  • Tekla Capital Management held 114,070 shares of Elevance Health worth $50.7M as of Q2 2023.
  • Tekla Capital Management left its Elevance Health share count unchanged in Q2 2023.
  • Elevance Health made up 1.98% of Tekla Capital Management's portfolio in Q2 2023, its #16 holding.
  • Tekla Capital Management first reported a position in Elevance Health in Q3 2017 and has held it in 24 quarters since.
  • Tekla Capital Management's Elevance Health position peaked at $59.1M in Q1 2021.
  • 1,524 funds tracked by Wall St. Rank held Elevance Health as of Q2 2023.

Based on Tekla Capital Management's 13F filing for Q2 2023, filed 10 Aug 2023.